image
Healthcare - Medical - Devices - NASDAQ - US
$ 95.18
1.27 %
$ 3.22 B
Market Cap
87.27
P/E
CASH FLOW STATEMENT
48.8 M OPERATING CASH FLOW
474.60%
-129 M INVESTING CASH FLOW
33.33%
22.9 M FINANCING CASH FLOW
-94.29%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis TransMedics Group, Inc.
image
00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)(140m)(140m)(160m)(160m)(180m)(180m)(200m)(200m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 35.5 M
Depreciation & Amortization 19.8 M
Capital Expenditures 0
Stock-Based Compensation 0
Change in Working Capital 0
Others 48.8 M
Free Cash Flow -80.9 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income 0 (25.0) (36.2) (44.2) (28.7) (33.5) (23.8) (20.8) (24.1)
Depreciation & Amortization 0 8.2 3.5 1.8 1.6 1.2 0.8 0.6 0.4
Deferred Income Tax 0 (1.7) 0 2.3 (0.4) 0.3 1.0 (0.3) 0.3
Stock Based Compensation 0 19.8 10.3 6.9 2.4 0.9 0.1 70 K 45 K
Other Operating Activities 48.8 30.0 3.4 1.4 0.5 0.5 0.2 93 K 65 K
Change in Working Capital 0 (44.3) (26.8) 3.0 (5.6) (1.6) (4.3) (2.8) (0.9)
Cash From Operations 48.8 (13.0) (45.8) (28.9) (30.3) (32.3) (26.0) (23.1) (24.1)
INVESTING CASH FLOW
Capital Expenditures 0 (179.1) (11.9) (3.5) (0.5) (0.2) (0.4) (0.3) (1.5)
Other Items (129.3) (14.9) 66.4 32.8 (41.1) (60.3) 12.7 25.1 (38.2)
Cash From Investing Activities (129.3) (194.0) 54.5 29.3 (41.6) (60.5) 12.3 24.9 (39.7)
FINANCING CASH FLOW
Common Stock Repurchased 0 1.0 0 0.4 0 0 0 0 0
Total Debt Repaid 0 445.4 22.5 0 0 0 24.4 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 22.9 (52.1) 5.6 1.4 0.6 (4.6) (2.3) 3 K 63.5
Cash From Financing Activities 22.9 400.4 167.9 1.4 75.5 92.7 22.1 3 K 63.5
CHANGE IN CASH
Net Change In Cash (58.2) 193.6 175.6 1.0 4.5 (0.1) 8.3 2.1 (0.2)
FREE CASH FLOW
Free Cash Flow (80.9) (192.1) (57.7) (32.4) (30.7) (32.5) (26.4) (23.4) (25.6)